184 related articles for article (PubMed ID: 34206021)
21. Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris.
Korita I; Bulo A; Langlois MR; Verhoye E; Blaton V
Clin Biochem; 2013 Nov; 46(16-17):1660-3. PubMed ID: 23994331
[TBL] [Abstract][Full Text] [Related]
22. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes.
Plump AS; Azrolan N; Odaka H; Wu L; Jiang X; Tall A; Eisenberg S; Breslow JL
J Lipid Res; 1997 May; 38(5):1033-47. PubMed ID: 9186920
[TBL] [Abstract][Full Text] [Related]
23. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
[TBL] [Abstract][Full Text] [Related]
24. High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease.
Chen GL; Liu LW; Xie S; Liu H; Liu YQ; Li YS
Chin Med J (Engl); 2010 Mar; 123(6):658-63. PubMed ID: 20368082
[TBL] [Abstract][Full Text] [Related]
25. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
26. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
Dueland S; France D; Wang SL; Trawick JD; Davis RA
J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
[TBL] [Abstract][Full Text] [Related]
28. Increasing apoA-I production as a target for CHD risk reduction.
Dullens SP; Plat J; Mensink RP
Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):616-28. PubMed ID: 17703927
[TBL] [Abstract][Full Text] [Related]
29. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARγ in HepG2 cells.
Du Y; Wang L; Si S; Yang Y; Hong B
Atherosclerosis; 2015 Apr; 239(2):589-98. PubMed ID: 25734982
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process.
Cuellar LÁ; Prieto ED; Cabaleiro LV; Garda HA
Biochim Biophys Acta; 2014 Jan; 1841(1):180-9. PubMed ID: 24201377
[TBL] [Abstract][Full Text] [Related]
31. Formation of new HDL particles from lipid-free apolipoprotein A-I.
Clay MA; Barter PJ
J Lipid Res; 1996 Aug; 37(8):1722-32. PubMed ID: 8864956
[TBL] [Abstract][Full Text] [Related]
32. Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.
Kim MH; de Beer MC; Wroblewski JM; Charnigo RJ; Ji A; Webb NR; de Beer FC; van der Westhuyzen DR
J Lipid Res; 2016 Jun; 57(6):969-79. PubMed ID: 27018443
[TBL] [Abstract][Full Text] [Related]
33. Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I.
Gkolfinopoulou C; Bourtsala A; Chroni A
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158593. PubMed ID: 31863971
[TBL] [Abstract][Full Text] [Related]
34. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
[TBL] [Abstract][Full Text] [Related]
35. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
37. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
Sviridov D; Pyle L; Fidge N
Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
[TBL] [Abstract][Full Text] [Related]
38. Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner.
Abe-Dohmae S; Kato KH; Kumon Y; Hu W; Ishigami H; Iwamoto N; Okazaki M; Wu CA; Tsujita M; Ueda K; Yokoyama S
J Lipid Res; 2006 Jul; 47(7):1542-50. PubMed ID: 16607034
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
Qin S; Liu T; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
[TBL] [Abstract][Full Text] [Related]
40. Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster.
Woollett LA; Kearney DM; Spady DK
J Lipid Res; 1997 Nov; 38(11):2289-302. PubMed ID: 9392427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
